HIGHLIGHTS
- who: Ruthenium-Based Polyoxometalate and collaborators from the Department of Chemical Sciences, University of Padova, Padova, Italy, CNR Institute of Biomolecular Chemistry, University of have published the Article: Mechanism of CK2 Inhibition by a Ruthenium-Based Polyoxometalate, in the Journal: (JOURNAL) of 21/01/2022
- what: Owing to these results, the authors focused this study on Ru4POM. In the experiments described so far, the activity of recombinant CK2α was evaluated at the optimal in_vitro conditions, namely at pH 7.5 and in the absence of NaCl. The authors show that Ru4POM competes with the substrates . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.